Camille Hizon, Mha
About Camille Hizon, Mha
Camille Hizon is a Life Sciences Strategy Analyst at ClearView Healthcare Partners in New York, where she has worked since 2021. She has a background in neuroscience, cognitive science, and health administration, with experience in project management and data analytics across various healthcare organizations.
Work at ClearView Healthcare Partners
Camille Hizon has been employed at ClearView Healthcare Partners as a Life Sciences Strategy Analyst since 2021. In this role, she focuses on providing strategic insights and analysis within the life sciences sector. Her work involves evaluating market trends, conducting competitive analysis, and supporting clients in making informed decisions regarding their product strategies. Based in New York, New York, she has contributed to various projects aimed at enhancing the efficiency and effectiveness of healthcare strategies.
Education and Expertise
Camille Hizon holds a Master of Health Administration from the University of Southern California, which she completed from 2019 to 2021. Prior to this, she earned two Bachelor of Science degrees from the University of Arizona in Neuroscience and Cognitive Science, and Molecular and Cellular Biology, both achieved between 2015 and 2019. Her educational background provides her with a strong foundation in health care management and scientific research, enhancing her analytical capabilities in the life sciences field.
Background
Camille Hizon has a diverse professional background in healthcare and research. She began her career as a Research Project Team Lead at the University of Arizona, where she led a team in a neurogenetics lab focused on developing animal models for ALS and dementia. She then transitioned to various roles, including Project Management Intern at Allergan and Data Analytics Intern at High Lantern Group. Her experience spans multiple facets of healthcare, including project management, data analytics, and operational strategy.
Achievements
During her tenure at Allergan, Camille Hizon developed a standard framework for preclinical project workstreams, aimed at streamlining processes and expediting regulatory drug approval for ophthalmologic gene therapies. Additionally, while at Optum, she leveraged her industry knowledge to balance patient outcomes with cost-effectiveness in projects that included COVID-19 testing operational strategy and quality improvement for wraparound care services. Her contributions reflect her commitment to enhancing healthcare delivery and outcomes.